Mark Mercola
Overview
Explore the profile of Mark Mercola including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
4765
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Belle K, Kreymerman A, Young J, Vadgama N, Ji M, Randhawa S, et al.
Mol Genet Metab
. 2025 Feb;
144(3):109049.
PMID: 39986240
No abstract available.
2.
Ruiz-Lozano P, Mercola M
Nat Cardiovasc Res
. 2024 Nov;
3(12):1375-1376.
PMID: 39587265
No abstract available.
3.
Kandasamy A, Yeh Y, Serrano R, Mercola M, Del Alamo J
bioRxiv
. 2024 Jul;
PMID: 39026786
Traction Force Microscopy (TFM) is a versatile tool to quantify cell-exerted forces by imaging and tracking fiduciary markers embedded in elastic substrates. The computations involved in TFM are ill-conditioned, and...
4.
Monte E, Furihata T, Wang G, Perea-Gil I, Wei E, Chaib H, et al.
bioRxiv
. 2024 May;
PMID: 38798547
Background: There is growing evidence that pathogenic mutations do not fully explain hypertrophic (HCM) or dilated (DCM) cardiomyopathy phenotypes. We hypothesized that if a patient's genetic background was influencing cardiomyopathy...
5.
Kepreotis S, Oh J, Park M, Yoo J, Lee C, Mercola M, et al.
Mol Ther Nucleic Acids
. 2024 Apr;
35(2):102174.
PMID: 38584818
Dystrophic cardiomyopathy is a significant feature of Duchenne muscular dystrophy (DMD). Increased cardiomyocyte cytosolic calcium (Ca) and interstitial fibrosis are major pathophysiological hallmarks that ultimately result in cardiac dysfunction. MicroRNA-25...
6.
Belle K, Kreymerman A, Vadgama N, Ji M, Randhawa S, Caicedo J, et al.
medRxiv
. 2023 Nov;
PMID: 37961166
Patients with mitochondrial disorders present with clinically diverse symptoms, largely driven by heterogeneous mutations in mitochondrial-encoded and nuclear-encoded mitochondrial genes. These mutations ultimately lead to complex biochemical disorders with a...
7.
Serrano R, Feyen D, Bruyneel A, Hnatiuk A, Vu M, Amatya P, et al.
Cell Stem Cell
. 2022 Dec;
30(1):86-95.e4.
PMID: 36563695
Drug safety initiatives have endorsed human iPSC-derived cardiomyocytes (hiPSC-CMs) as an in vitro model for predicting drug-induced cardiac arrhythmia. However, the extent to which human-defined features of in vitro arrhythmia...
8.
Wood E, Kreymerman A, Kowal T, Buickians D, Sun Y, Muscat S, et al.
Prog Retin Eye Res
. 2022 Dec;
96:101153.
PMID: 36503723
Optogenetics is defined as the combination of genetic and optical methods to induce or inhibit well-defined events in isolated cells, tissues, or animals. While optogenetics within ophthalmology has been primarily...
9.
Peters M, Maas R, van Adrichem I, Doevendans P, Mercola M, Saric T, et al.
Stem Cells Transl Med
. 2022 Aug;
11(10):1040-1051.
PMID: 36018047
The development of new cardioprotective approaches using in vivo models of ischemic heart disease remains challenging as differences in cardiac physiology, phenotype, and disease progression between humans and animals influence...
10.
Pandrala M, Bruyneel A, Hnatiuk A, Mercola M, V Malhotra S
J Med Chem
. 2022 Aug;
65(16):10898-10919.
PMID: 35944901
Development of tyrosine kinase inhibitors (TKIs) targeting the BCR-ABL oncogene constitutes an effective approach for the treatment of chronic myeloid leukemia (CML) and/or acute lymphoblastic leukemia. However, currently available inhibitors...